comparemela.com

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's specialty testing capabilities.

Related Keywords

William Blair ,Invitae Corporation ,Biopharma Laboratory Services ,Base Business ,Laboratory Services ,Diagnostics Laboratories ,Swipe Out ,Weak Guidance ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.